The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Magnetic and Fluorescent Nanoparticles for Multimodality Imaging
Abstract
The development of nanoparticulate contrast agents is providing an increasing contribution to the field of diagnostic and molecular imaging. Such agents provide several advantages over traditional compounds. First, they may contain a high payload of the contrast-generating material, which greatly improves their detectability. Second, multiple properties may be easily integrated within one nanoparticle to allow its detection with several imaging techniques or to include therapeutic qualities. Finally, the surface of such nanoparticles may be modified to improve circulation half-lives or to attach targeting groups. Magnetic resonance imaging and optical techniques are highly complementary imaging methods. Combining these techniques would therefore have significant advantages and may be realized through the use of nanoparticulate contrast agents. This review gives a survey of the different types of fluorescent and magnetic nanoparticles that have been employed for both magnetic resonance and optical imaging studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles
Dubertret, B., Skourides, P., Norris, D. J., Noireaux, V., Brivanlou, A. H., & Libchaber, A. (2002) · Science · doi:10.1126/science.1077194 · Cited by 3,019
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · cited 1×
“This can be realized with nanotechnology, which offers the exciting possibility of creating sensitive, targeted and macromolecular contrast agents that have multiple properties integrated [23].”
BackgroundExploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
Winter, P. M., Morawski, A. M., Caruthers, S. D., Fuhrhop, R. W., Zhang, H., Williams, T. A., Allen, J. S., Lacy, E. K., Robertson, J. D., Lanza, G. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000093185.16083.95 · Cited by 696 · cited 3×
“A variety of molecular markers have been visualized using perfluorocarbon nanoparticles, including fibrin [108], αvβ3-integrin [54,60,110] and tissue factor [10].”
BackgroundMethodNahrendorf, M., Jaffer, F. A., Kelly, K. A., Sosnovik, D. E., Aikawa, E., Libby, P., & Weissleder, R. (2006) · Circulation · doi:10.1161/circulationaha.106.646380 · Cited by 602
A Novel Site-Targeted Ultrasonic Contrast Agent With Broad Biomedical Application
Lanza, G. M., Wallace, K. D., Scott, M. J., Cacheris, W. P., Abendschein, D. R., Christy, D. H., Sharkey, A. M., Miller, J. G., Gaffney, P. J., & Wickline, S. A. (1996) · Circulation · doi:10.1161/01.cir.94.12.3334 · Cited by 406 · cited 2×
“Furthermore, these latter nanoparticles have been made specific for other imaging modalities, such as nuclear imaging [61], ultrasound [62] and optical techniques [61,63].”
BackgroundMethodWinter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235724.11299.76 · Cited by 379
Cited by
Aggregation-Induced Emission: Together We Shine, United We Soar!
Mei, J., Leung, N. L. C., Kwok, R. T. K., Lam, J. W. Y., & Tang, B. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00263 · Cited by 8,270
Applications of Nanoparticles in Biology
De, M., Ghosh, P. S., & Rotello, V. M. (2008) · Advanced Materials · doi:10.1002/adma.200703183 · Cited by 1,547
Multimodality Imaging Probes: Design and Challenges
Louie, A. (2010) · Chemical Reviews · doi:10.1021/cr9003538 · Cited by 1,044
Lanthanide‐Containing Light‐Emitting Organic–Inorganic Hybrids: A Bet on the Future
Carlos, L. D., Ferreira, R. A. S., Bermudez, V. D. Z., & Ribeiro, S. J. L. (2009) · Advanced Materials · doi:10.1002/adma.200801635 · Cited by 945
Park, Y. I., Kim, J. H., Lee, K. T., Jeon, K., Na, H. B., Yu, J. H., Kim, H. M., Lee, N., Choi, S. H., Baik, S., et al. (2009) · Advanced Materials · doi:10.1002/adma.200901356 · Cited by 585
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., & Lammers, T. (2015) · Chemical Reviews · doi:10.1021/cr500314d · Cited by 480
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Self-citationNanoparticle contrast agents for computed tomography: a focus on micelles
Cormode, D. P., Naha, P. C., & Fayad, Z. A. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1551 · Cited by 362
Self-citationConvection-enhanced delivery of nanocarriers for the treatment of brain tumors
Allard, E., Passirani, C., & Benoit, J.-P. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.003 · Cited by 294
Monocyte-Directed RNAi Targeting CCR2 Improves Infarct Healing in Atherosclerosis-Prone Mice
Majmudar, M. D., Keliher, E. J., Heidt, T., Leuschner, F., Truelove, J., Sena, B. F., Gorbatov, R., Iwamoto, Y., Dutta, P., Wojtkiewicz, G., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000116 · Cited by 292
Cell Uptake and in Vitro Toxicity of Magnetic Nanoparticles Suitable for Drug Delivery
Häfeli, U. O., Riffle, J. S., Harris-Shekhawat, L., Carmichael-Baranauskas, A., Mark, F., Dailey, J. P., & Bardenstein, D. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900083m · Cited by 277
Nanotechnology in Medical Imaging: Probe Design and Applications
Cormode, D. P., Skajaa, T., Fayad, Z. A., & Mulder, W. J. M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165506 · Cited by 275
Self-citationThe use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices
Hajba, L., & Guttman, A. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.02.001 · Cited by 111
de Maar, J. S., Sofias, A. M., Porta Siegel, T., Vreeken, R. J., Moonen, C., Bos, C., & Deckers, R. (2020) · Theranostics · doi:10.7150/thno.38625 · Cited by 71
Metadata
- Authors
- Mulder, W. J., Griffioen, A. W., Strijkers, G. J., Cormode, D. P., Nicolay, K., & Fayad, Z. A.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2007-06
- Volume
- 2
- Issue
- 3
- Pages
- 307-324
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2164883654
- Cited by
- 182
- References
- 11
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.